Business Wire

Warburg Pincus Establishes European Defence Investment Platform

10.4.2026 09:00:00 CEST | Business Wire | Press Release

Share

Warburg Pincus, the pioneer of private equity global growth investing, today announced the commencement of a dedicated European defence investment platform, reflecting the firm’s view that the sector is benefiting from sustained structural tailwinds and long-term policy support across the region. MEAG, as asset manager of Munich Re Group, will support the strategy as an early backer in the investment platform.

The proposed investment platform will complement existing capabilities while maintaining a dedicated European defence focus. As European governments and institutions accelerate investment in defence capabilities, resilience and strategic sovereignty, the proposed platform seeks to position Warburg Pincus to deploy capital into defence and adjacent strategic industries across Europe.

“Europe is undergoing a fundamental reassessment of its defence, resilience and security needs, leading to significant need for scaling of the European Defence sector,” said Tobias Weidner, Managing Director and head of the European Industrials team at Warburg Pincus. “We believe this creates a compelling long-term opportunity to support the growth of high-quality businesses operating in critical, strategic sectors, drawing on our experience investing in Aerospace and Defence and broader industrials.”

“Defence and security are strategically important sectors, given their role in supporting European resilience. Warburg Pincus is a natural partner based on our long-standing relationship and their deep sector expertise in Aerospace and Defence with a multi-decade track record building market-leading companies. We look forward to working together to back high-quality European businesses in this space,” said Nicholas Gartside, Member of the Board of Munich Re and Chief Investment Officer of Munich Reinsurance Company.

Warburg Pincus has a long track record of partnering with management teams and founders across Europe and globally. The firm brings significant experience across core Aerospace and Defence and adjacent industrial sectors globally, supported by more than 20 years of industrials investing and over 40 years of investing in Europe through multiple economic cycles. Current and former Aerospace and Defence platforms include Consolidated Precision Products (CPP), Triumph Group, INRCORE, Wencor Group, Extant Aerospace and TransDigm in the U.S., Inmarsat and Accelya in Europe and Quest Global in India.

In recent years, Warburg Pincus has also further strengthened its senior advisory capabilities in the defence and national security space, assembling a group of highly experienced European and transatlantic leaders. This includes:

  • Admiral Joachim Georg Rühle (Retired 4 Star Admiral), former Chief of Staff at NATO’s Supreme Headquarters Allied Powers Europe (SHAPE) and former Vice Chief of Defence of the German Armed Forces;
  • Susanne Wiegand, a senior executive with more than 20 years of leadership experience across the defence, mechanical engineering and marine industries, including as Chair and CEO of RENK Group AG and former CEO of Rheinmetall’s Electronic Solutions division;
  • Lieutenant General Jürgen-Joachim von Sandrart (Retired 3 Star General), with four decades of service in the German Army and former commander of NATO’s Multinational Corps Northeast and a senior advisor on security and defence policy in Germany; and
  • Rolf Wirtz, a senior defence executive and former officer in the German armed forces, with decades of leadership across military aircraft and UAV, defence electronics, and naval systems, including as CEO of Atlas Elektronik and as CEO of TKMS.

This deep bench of advisors is expected to work closely alongside the firm’s experienced Aerospace and Defence investment professionals based across Europe and the U.S., combining strategic, operational and policy expertise with Warburg Pincus’ global sourcing capabilities and value-creation platform.

About Warburg Pincus

Warburg Pincus LLC is the pioneer of global growth investing. A private partnership since 1966, the firm has the flexibility and experience to focus on helping investors and management teams achieve enduring success across market cycles. Today, the firm has more than $100 billion in assets under management, and more than 215 companies in its active portfolio, diversified across stages, sectors, and geographies. Warburg Pincus has invested in more than 1,100 companies across its private equity, real estate, and capital solutions strategies.

The firm is headquartered in New York with more than 15 offices globally. For more information, please visit www.warburgpincus.com or follow us on LinkedIn and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260410960904/en/

Contacts

Media:
Alice Gibb - Director, Europe Communications
Alice.gibb@warburgpincus.com
+44 207 306 3090

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments18.4.2026 22:12:00 CEST | Press Release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness. “We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental health crisis facing millions of Americans and the potential impact FDA-approved psychedelics could have,” said Kabir Nath, CEO at Compass Pathways. “Today’s announcement aligns regulatory urgency with patient need, and we applaud the Administration for taking this important step forward in accelerating access, without compromising rigorous science. Compass is conducting the largest, most robust classic psychedelic studies to date with COMP360 synthetic psilocybin. We have recently reported two positive phase 3 trials in treatment-resistant depression (TRD) with highly statistically significant and clinically meaningful data that

Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments18.4.2026 22:12:00 CEST | Press Release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness. “We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental health crisis facing millions of Americans and the potential impact FDA-approved psychedelics could have,” said Kabir Nath, CEO at Compass Pathways. “Today’s announcement aligns regulatory urgency with patient need, and we applaud the Administration for taking this important step forward in accelerating access, without compromising rigorous science. Compass is conducting the largest, most robust classic psychedelic studies to date with COMP360 synthetic psilocybin. We have recently reported two positive phase 3 trials in treatment-resistant depression (TRD) with highly statistically significant and clinically meaningful data that

2026 NAB Show Opens Tomorrow, Uniting Global Media Leaders to Shape the Future of Storytelling18.4.2026 04:08:00 CEST | Press Release

The 2026 NAB Show kicks off Saturday, April 18, with the show floor and exhibits opening on April 19, highlighting the most innovative companies and bringing together the world’s most influential voices across media, entertainment and technology for the industry’s premier global event. As the only platform that convenes broadcasters, media companies, content creators and technology innovators at scale, NAB Show continues its century-long legacy as the catalyst for innovation, growth and deal-making in a rapidly evolving, multi-platform world. From artificial intelligence and the creator economy to sports, streaming and cloud transformation, NAB Show is where the tools, talent and ideas driving the future of storytelling converge. “NAB Show is where the global media ecosystem comes together not just to explore what’s next—but to build it,” said Karen Chupka, executive vice president, National Association of Broadcasters. “This year’s Show reflects the accelerating pace of innovation and

2026 NAB Show Opens Tomorrow, Uniting Global Media Leaders to Shape the Future of Storytelling18.4.2026 04:08:00 CEST | Press Release

The 2026 NAB Show kicks off Saturday, April 18, with the show floor and exhibits opening on April 19, highlighting the most innovative companies and bringing together the world’s most influential voices across media, entertainment and technology for the industry’s premier global event. As the only platform that convenes broadcasters, media companies, content creators and technology innovators at scale, NAB Show continues its century-long legacy as the catalyst for innovation, growth and deal-making in a rapidly evolving, multi-platform world. From artificial intelligence and the creator economy to sports, streaming and cloud transformation, NAB Show is where the tools, talent and ideas driving the future of storytelling converge. “NAB Show is where the global media ecosystem comes together not just to explore what’s next—but to build it,” said Karen Chupka, executive vice president, National Association of Broadcasters. “This year’s Show reflects the accelerating pace of innovation and

Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product17.4.2026 23:43:00 CEST | Press Release

The U.S. Food and Drug Administration (FDA) announced that it has authorized the renewal of modified risk tobacco product (MRTP) orders previously granted to PMI for two versions of the IQOS device and three variants of the tobacco consumables, commercialized under the HEETS brand. This renewal allows PMI to continue sharing reduced-exposure information with U.S. adults 21+ who use traditional tobacco products, such as combustible cigarettes. The agency concluded that renewing the IQOS and HEETS MRTP authorizations is appropriate to promote public health and is expected to benefit the health of the population as a whole taking into account both users of tobacco products and persons who do not currently use tobacco products. “As the only company to have successfully secured and maintained MRTP authorizations for heated tobacco products in the U.S., we are confident that our science-based alternatives can help adult smokers transition away from combustible cigarettes,” said Stacey Kenned

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye